Lannett announces FDA acceptance, as a priority original ANDA, of the generic Advair Diskus filing

1 June 2021 - Lannett  today announced the U.S. FDA has accepted the abbreviated new drug application for fluticasone propionate and ...

Read more →

Apotex medicines in New Zealand

31 May 2021 - Apotex has announced that it is leaving the New Zealand market. ...

Read more →

7 out of 10 Koreans want cheaper drug with same ingredient

27 May 2021 - Seven out of 10 Koreans want to lower the drug cost by choosing a cheaper generic ...

Read more →

PHARMAC to work with others to improve communication

21 May 2021 - PHARMAC accepts the Coroner’s comments that not all information about the brand change reached patients. ...

Read more →

The TGA claims Tenofovir Emtricitabine Sandoz is a first generic but is it?

22 April 2021 - Closer examination suggests otherwise. ...

Read more →

Oakrum Pharma and Aucta Pharma announce U.S. FDA approval of generic version of Jadenu Sprinkle (deferasirox granules)

22 March 2021 - Oakrum Pharma in collaboration with Aucta Pharmaceuticals announced today the U.S. approval of a generic version of ...

Read more →

Washington may become the second state to distribute its own generic drugs

17 March 2021 - A bill moving through the Washington legislature may make the state only the second in the ...

Read more →

PHARMAC’s drug switch

17 March 2021 - PHARMAC's generic drug swap for epilepsy treatment saved $30 million over five years. But for some ...

Read more →

Sun Pharma announces Drizalma Sprinkle (duloxetine delayed release capsules) is now covered by most Medicare Part D plans

9 March 2021 - Coverage for novel formulation of duloxetine now offered to 91% of lives in top 10 Medicare Part ...

Read more →

PHARMAC swapping epilepsy drugs 'cannot be discounted' as a cause of deaths — neurologist

4 March 2021 - An Auckland paediatric neurologist says PHARMAC's decision to switch to a generic version of an epilepsy drug ...

Read more →

PHARMAC knew of epilepsy drug change risks - inquest

24 February 2021 - PHARMAC knew there were clinical reasons some epilepsy patients would not tolerate a change to their ...

Read more →

PHARMAC knew of epilepsy drug change risks within some patients, but went ahead with switch

24 February 2021 - PHARMAC knew there were clinical reasons some epilepsy patients would not tolerate a change to their medicines.  ...

Read more →

Epilepsy drug deaths: Medsafe told PHARMAC it was 'not desirable' to switch brands

23 February 2021 - The medicines safety authority advised PHARMAC it was “not desirable” for patients to switch brands of ...

Read more →

Maker of epilepsy drug warned over quality control

23 February 2021 - The drug at the centre of an inquest into six epilepsy deaths was made at a plant ...

Read more →

Epilepsy drug deaths: Coronial inquiry into medication-linked deaths resumes

22 February 2021 - A coronial inquiry into the deaths of six patients whose epilepsy medication was changed before they ...

Read more →